Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Put Call Ratio Amzn ($PCAM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [INDEX]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.52 +44.23%
on 02/18/21
0.89 -15.73%
on 02/26/21
+0.19 (+33.93%)
since 02/01/21
Bosnia receives jabs from Serbia amid COVAX dispute

SARAJEVO, Bosnia-Herzegovina (AP) — Bosnia on Tuesday received 10,000 vaccines from neighboring Serbia amid a dispute with the international COVAX mechanism over a delay in planned shipments.

Target powers through a pandemic; 2020 sales growth explodes

NEW YORK (AP) — Target extended its strong streak through the holiday quarter and sales grew by more than $15 billion in a pandemic year, exceeding the company's annual sales growth over the past 11 years combined.

M : 15.42 (+0.65%)
HD : 261.00 (-0.24%)
TGT : 187.50 (+0.76%)
WMT : 131.88 (+0.39%)
EU slaps sanctions on 4 Russia officials over Navalny arrest

BRUSSELS (AP) — The European Union on Tuesday imposed sanctions on four senior Russian officials over the jailing of opposition leader Alexei Navalny, who is President Vladimir Putin’s most high-profile political foe.

Alarm grows in Serbia over virus surge; lockdown urged

BELGRADE, Serbia (AP) — Serbian health experts urged the government on Tuesday to introduce a state of emergency and a strict lockdown to halt a surge in coronavirus infections that they say threaten the Balkan nation's health care system.

The Latest: AP source: Merck to help produce J&J vaccine

WASHINGTON — A Biden administration official says drugmaker Merck will help produce rival Johnson & Johnson’s newly-approved coronavirus vaccine.

PFE : 33.72 (+0.09%)
JNJ : 159.80 (+0.30%)
Official: Merck to help produce rival J&J's COVID-19 vaccine

WASHINGTON (AP) — Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, a Biden administration official confirmed Tuesday.

Key Turning Points

3rd Resistance Point 0.75
2nd Resistance Point 0.75
1st Resistance Point 0.75
Last Price 0.75
1st Support Level 0.75
2nd Support Level 0.75
3rd Support Level 0.75

See More

52-Week High 0.89
Fibonacci 61.8% 0.75
Last Price 0.75
Fibonacci 50% 0.70
Fibonacci 38.2% 0.66
52-Week Low 0.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar